KABIVEN
INF EML 4X2053ML II
Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
---|---|---|---|---|
Resumption of marketing | 20.04.2021 | |||
Interruption of marketing | 07.04.2021 |
0107105 |
Capacity/distribution reasons | 30.04.2021 |
Placing on the market | 16.10.2008 |
All reports are available in the Overview.